This work was aimed at exploring the efficacy of
Ginkgo biloba extract combined with
hormones in the treatment of
sudden deafness and the influence on the reactivity of peripheral blood T cell subsets (PBTCSs). In this work, 64 patients with
sudden deafness who were treated in The First Affiliated Hospital of Hunan University of
Traditional Chinese Medicine from August 2019 to August 2022 were selected as the research objects. The patients were randomly divided into a
hormone group (treatment with
prednisone acetate, n = 34) and a combination group (treatment with Ginkgo-Damole combined with
prednisone acetate,
n = 30). After the two groups of patients were treated in different ways, their efficacy, symptom improvement, changes in blood rheology, and PBTCSs were compared. The total effective rates (TERs) of the
hormone group and the combination group were 76.32% and 95.73%, respectively (P < 0.05). The
fibrinogen contents of the patients in the combination group were obviously lower than those in the
hormone group after 5 d, 7 d, and 10 d of treatment (P < 0.05). The high blood viscosity (HBV) values of patients in the combination group at 5 d, 7 d, and 10 d
after treatment were greatly lower than those in the
hormone group (P < 0.05). The low blood viscosity (LBV) values after 3 d, 7 d, and 10 d of treatment in the combined group were much lower in contrast to those in the
hormone group (P < 0.05). The CD3+, CD4+, and CD4+/CD8+ in peripheral blood in the combination group were sharply higher while the CD8+ in the combined group was lower in contrast to the
hormone group (P < 0.05). There was no visible difference in the incidence of adverse reactions between the two groups of patients
after treatment (P > 0.05). In conclusion, the combined application of
Ginkgo biloba extract and
hormones could effectively improve the abnormal hemorheological indexes of patients with
sudden deafness and effectively relieve the imbalance of PBTCSs, which was safe.